PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund
12/28/2011 7:19:28 AM
More...
|
PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
6/27/2011 8:13:04 AM
More...
|
PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 Biotechnology Industry Organization (BIO) Business Forum During the Annual Biotechnology Industry Organization (BIO) International Convention in Washington, D.C.
6/24/2011 6:26:31 AM
More...
|
PharmacoFore, Inc. Announces Sponsorship of the 2011 CLAAD National Prescription Drug Abuse Prevention Policy Consensus Meeting on November 29, 2011 in Washington, DC
5/6/2011 7:59:44 AM
More...
|
PharmacoFore, Inc.'s Bio-Activated Molecular Delivery(TM) and MPAR(TM) Technologies to be Introduced by Dr. Lynn Webster at the 27th Annual American Academy of Pain Medicine Meeting
3/28/2011 7:55:44 AM
More...
|